GlassScriptPhysician profile
Connor Patrick Davis
NPI 1972277580
$1,858.68
in general payments reported to CMS, 2019-2025
14 companies · $467 in 2025
The $467 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $279 · 2022: $356 · 2023: $379 · 2024: $379 · 2025: $467.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,224.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $447.37 | 2022-2023 | |
| Getinge USA Sales, LLC | $329.16 | 2021-2023 | Vasoview Hemopro 2 |
| Novartis Pharmaceuticals Corporation | $202.61 | 2025 | |
| Abiomed | $147.36 | 2023 | Impella |
| Dermavant Sciences, INC. | $129.55 | 2024 | Vtama |
| Pfizer INC. | $127.11 | 2024 | |
| Genzyme Corporation | $106.25 | 2025 | |
| Janssen Biotech, INC. | $91.50 | 2024 | Tremfya |
| Organon LLC | $83.33 | 2025 | Vtama |
| Ucb, INC. | $74.32 | 2025 | Bimzelx |
| Edwards Lifesciences Corporation | $58.25 | 2023 | Edwards Intuity Elite Valve System, Mitris Resilia Mitral Valve |
| Cochlear Americas | $31.19 | 2021 | |
| Baxter Healthcare | $18.07 | 2024 | Preveleak |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $12.61 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connor Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.